Improving Reliability of Radiopharmaceuticals Synthesis System Used in Nuclear Medicine

2023

Closed access Metadata (CSL-JSON)
DOI 10.3850/978-981-18-8071-1_p596-cd
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

The use of radioactive isotopes in nuclear medicine is crucial for diagnosis and treatment of many diseases, and the multi-purpose synthesis system plays a vital role in producing radiopharmaceuticals.However, due to the harsh radioactive operational conditions, the system must have high reliability to avoid failures that could have serious consequences.The purpose of the work presented in this paper is to develop a probabilistic assessment of system reliability using a mathematical modelling based on graph issued from Hasse diagrams and a reliability block diagram to compare the results.By dividing the synthesis system into small subsystems, the reliability of each subsystem and its possible architectures has been quantified.This approach allows identifying the components that have crucial impact on system reliability and clarifying their failure rates, taking into account operational conditions.The results show that it is possible to assess the reliability of a multi-purpose synthesis system used to produce radiopharmaceuticals for nuclear medicine using the proposed modelling and probabilistic assessment approach.